Clinical Trial Update: Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector

View source ↗

Summary

A completed clinical trial evaluated the convenience and adherence of the Easypod electronic self-injector for growth hormone therapy in conditions including gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Growth Hormone Deficiency
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Growth Hormone Deficiency, Turner Syndrome | Status: COMPLETED